<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: The role of Helicobacter pylori in the pathogenesis of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>We determined the prevalence of cagA-positive (cagA+) H. pylori strains in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> or its complications compared with controls of similar age </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 153 consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> complicated by <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> were compared with 57 controls who underwent upper endoscopy for reasons other than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and CagA antibody status were determined by histology and enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: H. pylori prevalence was lower (34%) in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and its sequelae than in the control group (45.6%)(P = 0.15) </plain></SENT>
<SENT sid="5" pm="."><plain>Regardless of the group, increasing age was associated with higher prevalence of H. pylori (P = 0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>When compared with controls (42.3%), the prevalence of cagA+ H. pylori strains decreased (P = 0.008) in patients with more severe complications of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, 36.7% [nonerosive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, 41.2%; erosive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, 30.8%]; <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, 13.3%; and Barrett's with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>/<z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 0%) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Prevalence of H. pylori in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and its sequelae was lower but not significantly different than that of a control group </plain></SENT>
<SENT sid="8" pm="."><plain>However, patients carrying cagA+ strains of H. pylori may be protected against the complications of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, especially <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and its associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>